Bral CM[au] - Search Results

Year	Number of Results
1997	1
1998	2
2000	1
2002	2
2004	1
2007	1
2023	0

1

SCH 412499: biodistribution and safety of an adenovirus containing P21(WAF-1/CIP-1) following subconjunctival injection in Cynomolgus monkeys.

Veneziale RW, Bral CM, Sinha DP, Watkins RW, Cartwright ME, Rosenblum IY, Treinen KA, Kishnani NS, Nelson J, Chen Z, Faha B, Maneval D, Munger RJ, Cai XY, Cullen C, Arezzo JC. Veneziale RW, et al. Among authors: bral cm. Cutan Ocul Toxicol. 2007;26(2):83-105. doi: 10.1080/15569520701212167. Cutan Ocul Toxicol. 2007. PMID: 17612977

2

RNA polymerase II transcription complex assembly in nuclear extracts.

Bral CM, Steinke JW, Kang CJ, Peterson DO. Bral CM, et al. Gene Expr. 1998;7(3):191-204. Gene Expr. 1998. PMID: 9840811 Free PMC article.

3

Collagen suppresses the proliferative phenotype of allylamine-injured vascular smooth muscle cells.

Wilson E, Parrish AR, Bral CM, Williams ES, Ramos KS. Wilson E, et al. Among authors: bral cm. Atherosclerosis. 2002 Jun;162(2):289-97. doi: 10.1016/s0021-9150(01)00718-3. Atherosclerosis. 2002. PMID: 11996948

4

Benzo(a)pyrene-induced alterations in growth-related gene expression and signaling in precision-cut adult rat liver and kidney slices.

Parrish AR, Fisher R, Bral CM, Burghardt RC, Gandolfi AJ, Brendel K, Ramos KS. Parrish AR, et al. Among authors: bral cm. Toxicol Appl Pharmacol. 1998 Oct;152(2):302-8. doi: 10.1006/taap.1998.8525. Toxicol Appl Pharmacol. 1998. PMID: 9852999

5

Characterization of glomerular cell phenotypes following repeated cycles of benzo[a]pyrene injury in vitro.

Parrish AR, Alejandro NF, Bral CM, Kevin Kerzee J, Bowes RC, Ramos KS. Parrish AR, et al. Among authors: bral cm. Biochem Pharmacol. 2002 Jul 1;64(1):31-9. doi: 10.1016/s0006-2952(02)01054-7. Biochem Pharmacol. 2002. PMID: 12106603

6

Quantitative gene expression analysis in a nonhuman primate model of antibiotic-induced nephrotoxicity.

Davis JW 2nd, Goodsaid FM, Bral CM, Obert LA, Mandakas G, Garner CE 2nd, Collins ND, Smith RJ, Rosenblum IY. Davis JW 2nd, et al. Among authors: bral cm. Toxicol Appl Pharmacol. 2004 Oct 1;200(1):16-26. doi: 10.1016/j.taap.2004.02.001. Toxicol Appl Pharmacol. 2004. PMID: 15451304

7

Profiles of antioxidant/electrophile response element (ARE/EpRE) nuclear protein binding and c-Ha-ras transactivation in vascular smooth muscle cells treated with oxidative metabolites of benzo[a]pyrene.

Miller KP, Chen YH, Hastings VL, Bral CM, Ramos KS. Miller KP, et al. Among authors: bral cm. Biochem Pharmacol. 2000 Nov 1;60(9):1285-96. doi: 10.1016/s0006-2952(00)00439-1. Biochem Pharmacol. 2000. PMID: 11008122

8

Identification of benzo[a]pyrene-inducible cis-acting elements within c-Ha-ras transcriptional regulatory sequences.

Bral CM, Ramos KS. Bral CM, et al. Mol Pharmacol. 1997 Dec;52(6):974-82. doi: 10.1124/mol.52.6.974. Mol Pharmacol. 1997. PMID: 9415707

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results